Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful value well into the post-patent-loss future. Traditionally, LOE has led to a sharp decline in sales for small molecule drugs, with brand unit share falling […] Source